VitaLeech Bioscience Overview

  • Founded
  • 1999
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

VitaLeech Bioscience General Information


Developer of a recombinant enzyme designed for the treatment of periodontitis. The company's recombinant enzyme are for Periodonditis disorder a form of inflammation of the gum that may result in the loss of teeth among 40 year old.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • Erasmuslaan 2A
  • 4615 AB Bergen op Zoom
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VitaLeech Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC Completed Product Development
To view VitaLeech Bioscience’s complete valuation and funding history, request access »

VitaLeech Bioscience Executive Team (1)

Name Title Board Seat Contact Info
Willem van Lawick MD Director
To view VitaLeech Bioscience’s complete executive team members history, request access »